1Hammer RE,Maika SD,Richardson JA,et al.Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta Zm:an animal model of HLA-B27-associated human disorders.Cell,1990,63:1099-1112.
2Martinez-Borra J,Gonzalez S,Lopez-Vazquze A,et al.HLA-B27 alone rather than B27-related class Ⅰ haplotypes contributes to ankylosing spondylitis susceptibility.Hum Immunol,2000,61:131-139.
3Allen RL,Bowness P,McMicheal AJ.The role of HLA-B27 in spondyloarthritis.Immunogenetics,1999,50:220-227.
4Khare SD,Lee S,Bull MJ,et al.Peptide binding α2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice.Hum Immunol,1999,60:116-126.
5Garcia-Peydro M,Marti M,Lopez de Castro JA,et al.High T cell epitope sharing between two HLA-B27 subtypes (B2705 and B2709) differentially associated to ankylosing spondylitis.J Immunol,1999,163:2299-2305.
6Madden DR,Gorga JC,Stromingen JL,et al.The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.Cell,1992,70:1035-1048.
7Galocha B,Lamas JR,Villadangos JA,et al.Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B2704 and B2706 subtypes,and to mutants mimicking their polymorphism.Tissue Antigens,1996,48:509-518.
8Rudwaleit M,Bowness P,Wordsworth P.The nucleotide sequence of HLA-B2704 reveals a new amino acid substitution in exon 4 which is also present in HLA-B2706.Immunogenetics,1996,43:160-162.
9Benjamin R,Parham P.Guilt by association:HLA-B27 and ankylosing spondylitis.Immunol Today,1990,11:137-142.
10Lopez D,Garcia-Hoyo R,Lopez de Castro JA.Clonal analysis of alloreactive T cell responses against the closely related B2705 and B2703 subtypes.Implications for HLA-B27 association to spondyloarthropathy.J Immunol,1994,152:5557-5571.
